Perfil
Ming-Chou Lee formerly worked at Quest Diagnostics Infectious Disease, Inc., as Director-Molecular Research & Development, ArcherDX LLC, as Senior Director-Assay Development, PrimeraDx, Inc., as Vice President-Product Development, and Exagen, Inc., as Chief Technology Officer from 2021 to 2022.
Dr. Lee received his doctorate degree from The University of Alabama.
Antiguos cargos conocidos de Ming-Chou Lee.
| Empresas | Cargo | Fin |
|---|---|---|
| EXAGEN INC. | Director Técnico/Científico/I+D | 31/12/2022 |
Quest Diagnostics Infectious Disease, Inc.
Quest Diagnostics Infectious Disease, Inc. Miscellaneous Commercial ServicesCommercial Services Provides diagnostic services | Corporate Officer/Principal | - |
ArcherDX LLC
ArcherDX LLC Packaged SoftwareTechnology Services Develops software solutions for investigating cancer treatment | Corporate Officer/Principal | - |
PrimeraDx, Inc.
PrimeraDx, Inc. Medical SpecialtiesHealth Technology Develops and commercializes molecular diagnostics systems | Corporate Officer/Principal | - |
Formación de Ming-Chou Lee.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
PrimeraDx, Inc.
PrimeraDx, Inc. Medical SpecialtiesHealth Technology Develops and commercializes molecular diagnostics systems | Health Technology |
The University of Alabama
The University of Alabama Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quest Diagnostics Infectious Disease, Inc.
Quest Diagnostics Infectious Disease, Inc. Miscellaneous Commercial ServicesCommercial Services Provides diagnostic services | Commercial Services |
Exagen, Inc.
Exagen, Inc. Medical/Nursing ServicesHealth Services Operates as a commercial-stage diagnostics company | Health Services |
ArcherDX LLC
ArcherDX LLC Packaged SoftwareTechnology Services Develops software solutions for investigating cancer treatment | Technology Services |
- Bolsa de valores
- Insiders
- Ming-Chou Lee
















